0795 Quantifying Guideline Adherence: Sleep Testing in the Pediatric down Syndrome Population
Abstract
Down Syndrome (DS) is the most common chromosomal disorder, occurring in 1 in every 700 births. Clinically reported symptoms of obstructive sleep apnea (OSA), such as snoring, have been shown to be unreliable for predicting the presence of OSA in the DS population. With the prevalence of OSA in this vulnerable population estimated between 50-79%, and the lack of guidance that the traditional symptoms provide in clinical decision making, the American Academy of Pediatrics (AAP) recommends all children with DS be screened for OSA with polysomnography (PSG) before their 4th birthday. Previous studies conducted shortly after the publishing of these guidelines showed suboptimal adherence. Both DS and OSA impact medical costs over time, with OSA leading to a doubling of medical expenses (cite) and DS increasing it twelve-fold. Early diagnosis and treatment of OSA in children with Down Syndrome is imperative to improving morbidity in this patient population and lowering overall healthcare cost and utilization.
In this retrospective chart review, an electronic medical record (EMR) query for all patients aged 3-8 years, with a diagnosis of DS, and who live in Illinois was performed. The query included if any sleep clinic or PSG orders were placed and when these orders were completed. The query yielded a convenience sample of 582 children.
Only 26% (117) of the subjects had a sleep medicine clinic or PSG order in their chart with 21% (124) having completed a PSG, and 11% (62)…
Read the paper
Related studies
- Tryptophan Metabolism and Gut-Brain Homeostasis
- Rationale for a Multi-Factorial Approach for the Reversal of Cognitive Decline in Alzheimer’s Disease and MCI: A Review
- Prioritized Research for the Prevention, Treatment, and Reversal of Chronic Disease: Recommendations From the Lifestyle Medicine Research Summit
- Relationship between sleep disorders and gut dysbiosis: what affects what?
- The role of CLOCK gene in psychiatric disorders: Evidence from human and animal research
- Genetic, Transcriptome, Proteomic, and Epidemiological Evidence for Blood-Brain Barrier Disruption and Polymicrobial Brain Invasion as Determinant Factors in Alzheimer’s Disease
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.